Speaker illustration

Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

Member of:

European Society of Cardiology

Dr. Jurrien ten Berg, MD, PhD, MSc, FESC, FACC. St. Antonius Hospital, The Netherlands   Jurrien ten Berg is the Director of the Cardiology Training Program and Head of the St Antonius Center for Platelet Function Studies, at the St Antonius Hospital, the Netherlands.   Jurrien ten Berg received his medical degree from the University of Utrecht, the Netherlands before taking up a residency in cardiology at St Antonius Hospital. He did his PhD at the University of Nijmegen on Oral Anticoagulation in Percutanous Coronary Intervention (promotor Prof Verheugt). He recently read for Master of Science in Health Economics at the London School of Economics, the UK. His areas of expertise are acute coronary syndrome, antithrombotic treatment and interventional cardiology especially structural heart disease. He has published around 425 peer-reviewed publications (Pubmed). He is actively involved in research projects in the fields of antiplatelet therapy, PCI, TAVI, anticoagulation, stent throm

Congress committee e-posters choice in CAD/ACS/ACC

Event: ESC Congress 2021 - The Digital Experience

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Congress Committee e-posters Choice


Alcohol septal ablation of hypertrophic cardiomyopathy

Event: ESC CONGRESS 2019

Topic: Hypertrophic Cardiomyopathy

Session type: Live in the Box


Late Breaking Science in Acute Coronary Syndromes 2

Event: ESC CONGRESS 2019

Topic: Acute Coronary Syndromes

Session type: Late-Breaking Science


Bringing order to complexity: antithrombotic regimens for atrial fibrillation patients who underwent percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot


Clinical studies on platelet inhibition

Event: ESC CONGRESS 2016

Topic: Thrombosis and platelets

Session type: Rapid Fire Abstracts


This platform is supported by

logo Novo Nordisk